 |

May 23rd, 2012, 11:20 AM
|
 |
Membro del Comitato Consultivo, Editore e Direttore del Forum Italiano di FluTrackers
|
|
Join Date: Dec 2007
Location: Padua, Italy
Posts: 21,701
|
|
Preliminary Dose Estimation from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami (WHO, edited)
[Source: World Health Organization, full page: ( LINK). Edited.]
Preliminary Dose Estimation from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami
Authors: WHO
Publication details
Number of pages: 120
Publication date: 2012
Languages: English
ISBN: 9789241593662
Downloads: English pdf, 1.85Mb
Overview
The earthquake and tsunami in Japan on 11 March 2011 led to releases of radioactive material into the environment from the Fukushima Daiichi nuclear site. This report describes a preliminary estimate of radiation doses to the public resulting from this accident. These doses are assessed for different age groups in locations around the world, using assumptions described in the report. The dose assessment forms one part of the overall health risk assessment being carried out by WHO of the global impact of the accident at the Fukushima Daiichi nuclear power plant. The health risk assessment is the subject of a separate WHO report which will be published in Summer 2012.
-
-----
__________________
G_MICHIELI (aka IRONOREHOPPER)
|

May 23rd, 2012, 11:32 AM
|
 |
Membro del Comitato Consultivo, Editore e Direttore del Forum Italiano di FluTrackers
|
|
Join Date: Dec 2007
Location: Padua, Italy
Posts: 21,701
|
|
Re: Preliminary Dose Estimation from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami (WHO, edited)
Excerpt from the above mentioned report:
(...)
5. Summary and conclusions
The radiation doses in this report represent a preliminary assessment of doses for the first year after the Fukushima accident based on data available to the panel up to September 2011. Doses are provided for different populations by age and geographical location.
Effective doses and equivalent doses to the thyroid have been estimated for three age groups: 1-year-old infants, 10-year-old children, and adults. These age groups were chosen to enable the characterization of the radiological impact on younger and more sensitive populations. The estimated doses are those received by a characteristic person living in the region or location of interest, and are mostly reported as bands of one order of magnitude, providing a level of accuracy commensurate with the preliminary nature of the assessment. The bands do not indicate the range of doses in the population in the area, which would have required distributions of input data not available to the panel within the time frame of this assessment1.
In general, the doses assessed are the committed doses for residents staying in a given region or location during the full first year after the accident. However, in a few locations in the most affected part of Fukushima prefecture, doses were calculated for the first four months after the accident as relocation took place at some time during the first few months.
On the basis of the input data used for this assessment, extrapolation of doses beyond the first year was not performed because of uncertainties that may influence long-term exposure, including future protective and remedial actions, that will further reduce radiation exposure (48, 49). The experience of the Chernobyl accident was that about 30% of the lifetime dose was delivered during the first year and about 70% during the first 15 years (31). On the basis of environmental activity concentration data, it can be expected that the fraction of the lifetime dose beyond the first year will be lower for the Fukushima Daiichi nuclear power plant accident than for the Chernobyl accident, due to the greater influence of the shorter-lived 134CS (half-life two years) compared to 137CS (half-life 30 years).
In summary, the key features of the assessed doses are as follows.
For the estimated effective doses:
■■ In Fukushima prefecture the estimated effective doses are within a dose band of 1−10 mSv, except in two of the example locations where the effective doses are estimated to be within a dose band of 10–50 mSv.
■■ In prefectures neighbouring Fukushima, the estimated effective doses re within a dose band of 0.1−10 mSv, and in all other prefectures the effective doses are estimated to be within a dose band of 0.1−1 mSv. In the rest of the world estimated effective doses are less than 0.01 mSv, and are usually far below this level.
■■ The exposure pathways that contribute most to effective dose vary with location and distance from the site. In the most affected regions the external dose from groundshine is important, but with increasing distance from the site the ingestion of food becomes the main contributor.
For the estimated thyroid doses:
■■ In the most affected area of Fukushima prefecture the estimated thyroid doses are within the dose band of 10−100 mSv, with the exception of one example location where estimated thyroid doses to adults are within a dose band of 1−10 mSv and another example location where the estimated thyroid doses to infants are within a dose band of 100–200 mSv.
■■ In the rest of Fukushima prefecture the estimated thyroid doses are within a dose band of 1−10 mSv to adults and 10−100 mSv to children and infants.
■■ In the rest of Japan the estimated thyroid doses are within a dose band of 1−10 mSv.
■■ In the rest of the world, estimated thyroid doses are less than 0.01 mSv, and are usually far below this level.
■■ The exposure pathways that contribute most to thyroid dose vary with location and distance from the site. In the most affected regions, inhalation from the cloud and the external dose from groundshine are important, but with increasing distance from the site the ingestion of food becomes the main contributor.
It can be concluded that the estimated effective doses outside Japan from the Fukushima Daiichi nuclear power plant accident are below (and often far below) the dose levels regarded by the international radiological protection community as very small. An annual dose of 0.01 mSv (10 μSv) corresponds to the radiological criterion for exemption of materials from need of regulatory control and for clearance of materials from any further control, as established in the International Basic Safety Standards for protection Against Ionizing Radiation and for the Safety of Radiation Sources (38). This level of dose is comparable to the average population dose resulting from 1.5 days of exposure to natural background radiation/natural sources of radiation (37).
It can also be concluded that low effective doses are estimated in much of Japan. To put this into context, and keeping in mind that dose limits do not apply in emergency exposure situations, it could be noted that estimated effective doses outside Fukushima and neighbouring prefectures are below the annual limit for public exposure in planned exposure situations (1 mSv) (10,38).
In the Fukushima prefecture and in neighbouring prefectures the estimated effective doses are below the internationally agreed reference level for public exposure due to radon in dwellings (annual effective dose of about 10 mSv (39)), except in two locations in the most affected part of Fukushima prefecture where the effective doses were estimated to be within a dose band of 10–50 mSv. To put this into context, the ICRP recommends reference levels for planned residual dose in emergency exposure situations (the dose that remains after protective actions have been taken) in the band of 20–100 mSv annual or acute effective dose (48).
In view of the time frame of the assessment, a number of assumptions were taken to calculate the doses, which mostly provide conservative estimates. In particular the panel was aware of some protective measures taken by the Government of Japan in relocating residents of certain areas (i.e. in the “deliberate evacuation area”). Because of lack of the necessary detailed information, it has been assumed that the relocation of residents in these areas took place at least four months after the accident, whereas a proportion of the population was relocated earlier.
Therefore, the doses estimated in the example locations considered for the most affected areas of Fukushima prefecture may be overestimated. Moreover, the protective effects of sheltering may not also have been fully taken into account due to lack of more detailed information. This being said, the dominant contributors to the total effective dose in these locations were the inhalation2 and external exposure pathways. While evacuation prior to the arrival of the radioactive cloud would be effective in reducing inhalation and external exposure from cloudshine, relocation after the radioactive release (e.g. at two months instead of four months as assumed) would not significantly reduce the overall dose as the early exposure pathways would remain unchanged.
For prefectures far away from Fukushima included under the scenario for the rest of Japan, food appears to be the main exposure source. In these locations, food was not monitored and it assumed that consumers only ate food coming from Fukushima and neighbouring prefectures. The doses are therefore clearly overestimated.
Comparison between the estimated doses for Japan in this report and those estimated from direct measurements of radionuclides in Japanese residents and travellers returning from Japan gives confidence that the estimated doses in this report do not underestimate the actual doses in Japan. The doses estimated from in vivo human measurements are similar, and in some cases lower, than those estimated in the assessment using environmental data, although a direct correlation between the quantities cannot be made.
As discussed, cautious assumptions have been made where data are lacking. However, the panel considers that the doses presented here are unlikely to be very significantly overestimated.
The Independent Expert Panel considers that the dose estimates are robust on the basis of knowledge and information on hand at the time of the study. The data used as input to this assessment are considered by the panel to be the most appropriate available on the timescale required (September 2011) and to be fit-for-purpose.
The long-term priority in radiological protection after a nuclear accident is to protect people with the highest exposures, and to reduce all individual exposures associated with the event to as low as reasonably achievable (30). This requires the knowledge of the dose distribution for the subsequent optimization of protection.
It has been reported that a number of remedial actions have been taken by the Government of Japan, municipal authorities and residents to lower radiation exposure (49). At the time of publication of this report, additional protective and remedial actions are being implemented3. Such measures that will further lower exposure can be accounted for in future studies, such as the upcoming two-year UNSCEAR assessment.4
In addition to the UNSCEAR study, a major initiative initiated in the Fukushima prefecture will inform future more detailed dose assessments. This unprecedented initiative, the Fukushima Health Survey, includes a survey to determine the whereabouts of every prefectural resident from the time of the March 11 nuclear accident onwards (a so-called “record of movement”) and to provide the basis for estimating the level of radiation exposure, which will assist in future health effect assessments.
(...)
-
-----
__________________
G_MICHIELI (aka IRONOREHOPPER)
|
 |
|
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
|
|
|
| Thread Tools |
Search this Thread |
|
|
|
| Display Modes |
Linear Mode
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is On
|
|
|
Disclaimers:
The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.
The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.
Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.
This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.
Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.
Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright
we may be contacted concerning copyright matters at:
FluTrackers.com Inc.
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
Phone: 407-745-1513
E-Mail: flutrackers@earthlink.net
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.
For more information please visit:
http://www.law.cornell.edu/uscode/17/107.shtml
Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.
FluTrackers Does Not Provide Any Medical Advice:
FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.
These Disclaimers are subject to change at anytime.
Email the Webmaster with questions or comments about this site at flutrackers@earthlink.net
All times are GMT -5. The time now is 09:36 AM.
|